Safety and Tolerability of Glatiramer Acetate (GLACIER)
- Study Title
- Safety and Tolerability of Glatiramer Acetate
- Teva Identifier
- GA-MS-303
- ClinicalTrials.gov Identifier
- NCT01874145
- Study Status
- Completed
- Trial Condition(s)
- Relapsing-Remitting Multiple Sclerosis
- Interventions
- Drug: GA 20 mg/mL | Drug: GA 40 mg/mL
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 06/01/2013 - 05/01/2014
- Phase
- Phase 3
